NY Times Gets It Wrong On Impact Of Price Controls On New Drugs
Forbes: Drug Truths
SEPTEMBER 11, 2023
But, make no mistake – the IRA will have a major impact on biopharma R&D and, as a result, fewer important medicines will be available.
Sat.Sep 09, 2023 - Fri.Sep 15, 2023
275 
Daiichi Sankyo, with new data, to seek FDA approval of lung cancer drug
BioPharma Drive: Drug Pricing
SEPTEMBER 11, 2023
The HER3-targeting treatment could become the next antibody-drug conjugate to emerge from Daiichi Sankyo’s laboratories, after the AstraZeneca-partnered Enhertu.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Dental Issues Plague America's Nursing Home Residents
Drugs.com
SEPTEMBER 15, 2023
FRIDAY, Sept. 15, 2023 -- Good oral health is one of the keys to healthy aging, but a sobering new study shows that many U.S. nursing home residents have significant dental issues. Close to two in every 10 residents have missing teeth, about 8%.
Making hydrogen from waste plastic could pay for itself
Science Daily: Pharmacology News
SEPTEMBER 14, 2023
Researchers have found a way to harvest hydrogen from plastic waste using a low-emissions method that generates graphene as a by-product, which could help offset production costs.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
LAXAI Life Sciences Selects CDD Vault for Digital Transformation
Collaborative Drug
SEPTEMBER 12, 2023
Hyderabad and San Francisco, September 12, 2023 - LAXAI Life Sciences, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the adoption of the CDD Vault informatics platform. This strategic move underscores LAXAI’s commitment to combining science and innovation, reinforcing its clients’ competitive advantage through high-quality, efficient services.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
More Trending
A COVID Vaccine-by-Mouth Could Be on the Way
Drugs.com
SEPTEMBER 14, 2023
THURSDAY, Sept. 14, 2023 -- An oral vaccine for COVID-19 appears to produce the sort of immune response that could quickly stamp out a developing infection, according to results from a small-scale primate study. Some monkeys given an experimental.
Healthy lifestyle can help prevent depression -- and new research may explain why
Science Daily: Pharmacology News
SEPTEMBER 11, 2023
A healthy lifestyle that involves moderate alcohol consumption, a healthy diet, regular physical activity, healthy sleep and frequent social connection, while avoiding smoking and too much sedentary behavior, reduces the risk of depression, new research has found.
Recorded Webinar: Drug Design Trends in the Age of AI
Collaborative Drug
SEPTEMBER 15, 2023
Recorded Webinar: Drug Design Trends in the Age of AI. fragment-based drug design and full molecule-based drug design.
Flagship-backed Generate raises $273M as its first drugs move to the clinic
BioPharma Drive: Drug Pricing
SEPTEMBER 14, 2023
Since 2019, Generate has raised nearly $700 million in private financing and has now brought a monoclonal antibody into Phase 1 testing.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Depression Risk Rises in Folks Who Use Both Marijuana & Tobacco
Drugs.com
SEPTEMBER 13, 2023
WEDNESDAY, Sept. 13, 2023 -- Using both tobacco and marijuana is tied to significantly higher odds for depression and anxiety, a new study suggests. Among nearly 54,000 U.S. adults, those who used both substances experienced anxiety or depression.
New evidence indicates patients recall death experiences after cardiac arrest
Science Daily: Pharmacology News
SEPTEMBER 14, 2023
Up to an hour after their hearts had stopped, some patients revived by cardiopulmonary resuscitation (CPR) had clear memories afterward of experiencing death and had brain patterns while unconscious linked to thought and memory, report investigators.
CDD Vault User Group Meeting – Boston, October 4
Collaborative Drug
SEPTEMBER 14, 2023
CDD Vault User Group Meeting - Cambridge Innovation Center (CIC) Join the Collaborative Drug Discovery community to learn how CDD is being used every day
New startup Arialys takes aim at the immune system, hoping to create neuropsychiatry drugs
BioPharma Drive: Drug Pricing
SEPTEMBER 12, 2023
Arialys Therapeutics launched Tuesday with $58 million in funding from a group of life sciences investors that includes Johnson & Johnson’s venture arm.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
FDA Approves New COVID Booster Shots
Drugs.com
SEPTEMBER 11, 2023
MONDAY, Sept. 11, 2023 -- The U.S. Food and Drug Administration on Monday gave the green light to new COVID boosters for Americans, setting the stage for the updated vaccines to become available within days. The COVID-19 shots from Pfizer and.
Genetically modified bacteria break down plastics in saltwater
Science Daily: Pharmacology News
SEPTEMBER 14, 2023
Researchers have genetically engineered a marine microorganism to break down plastic in salt water. Specifically, the modified organism can break down polyethylene terephthalate (PET), a plastic used in everything from water bottles to clothing that is a significant contributor to microplastic pollution in oceans.
The Inflation Reduction Act Will Lead To Fewer New Medicines
Forbes: Drug Truths
SEPTEMBER 11, 2023
But, make no mistake – the IRA will have a major impact on biopharma R&D and, as a result, fewer important medicines will be available.
UK biotech AlveoGene launches with plans for inhaled gene therapy
BioPharma Drive: Drug Pricing
SEPTEMBER 14, 2023
The company is working on a treatment of alpha-1 antitrypsin deficiency, which it claims it can deliver direct to lung cells via a nebulizer.
Deliver Fast, Flexible Clinical Trial Insights with Spotfire
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
40% of Patients Recall Some Consciousness During Near Death Experiences
Drugs.com
SEPTEMBER 14, 2023
THURSDAY, Sept. 14, 2023 -- People have long talked about having near-death experiences in which they felt they were looking down on themselves while others tried to save them. Now, researchers have documented some of those experiences. In a study.
AI foundation model for eye care to supercharge global efforts to prevent blindness
Science Daily: Pharmacology News
SEPTEMBER 13, 2023
Researchers have developed an artificial intelligence (AI) system that has the potential to not only identify sight-threatening eye diseases but also predict general health, including heart attacks, stroke, and Parkinson's disease.
Structure-Based Optimization of Covalent, Small-Molecule Stabilizers of the 14-3-3?/ER? Protein–Protein Interaction from Nonselective Fragments
Covalent Modifiers
SEPTEMBER 9, 2023
Markella Konstantinidou, Emira J. Visser, Edmee Vandenboorn, Sheng Chen, Priyadarshini Jaishankar, Maurits Overmans, Shubhankar Dutta, R. Jeffrey Neitz, Adam R. Renslo, Christian Ottmann, Luc Brunsveld, and Michelle R. Arkin Journal of the American Chemical Society 2023 DOI: 10.1021/jacs.3c05161 The stabilization of protein–protein interactions (PPIs) has emerged as a promising strategy in chemical biology and drug discovery.
Moderna aims for the stars again with ambitious drug development plan
BioPharma Drive: Drug Pricing
SEPTEMBER 13, 2023
The biotech is telling investors it expects to launch as many as 15 new products in five years, a bold goal that will require a lot to go right to pull off.
Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
CDC Panel Gives Support to New COVID Booster Shots
Drugs.com
SEPTEMBER 12, 2023
TUESDAY, Sept. 12, 2023 -- Following on an approval granted Monday by the U.S. Food and Drug Administration, an expert panel from the Centers for Disease Control and Prevention late Tuesday also signed off on new COVID boosters for Americans. Final.
Earth's stability and ability to support civilization at risk: Six of nine planetary boundaries exceeded
Science Daily: Pharmacology News
SEPTEMBER 13, 2023
A new study updates the planetary boundary framework and shows human activities are increasingly impacting the planet and, thereby, increasing the risk of triggering dramatic changes in overall Earth conditions.
Phage Display of Two Distinct Warheads to Inhibit Challenging Proteins
Covalent Modifiers
SEPTEMBER 9, 2023
Mengmeng Zheng and Jianmin Gao ACS Chemical Biology 2023 DOI: 10.1021/acschembio.3c00297 Falling in between traditional small molecules and antibodies in size, peptides are emerging as a privileged therapeutic modality, one that can harness the benefits of both small molecule and antibody drugs. To discover potential peptide therapeutics, it is highly desirable to have high throughput screening platforms that can assess peptides with diverse and non-natural functional motifs.
2Seventy CEO Leschly to step down as company cuts staff, spending
BioPharma Drive: Drug Pricing
SEPTEMBER 12, 2023
Citing “near-term headwinds,” the cancer cell therapy developer will lay off 176 employees and pare back some of its research spending.
Gene Test Spots Those Vulnerable to Rare but Severe Side Effect of Drugs for MS, Other Conditions
Drugs.com
SEPTEMBER 13, 2023
WEDNESDAY, Sept. 13, 2023 -- A large number of drugs used to treat everything from multiple sclerosis to blood cancers to rheumatoid arthritis may cause a rare but often-fatal condition called progressive multifocal leukoencephalopathy (PML). But a.
Let's personalize your content